Connect Biopharma Holdings Limited directly listed its ordinary shares on Nasdaq on September 3, 2025, following the termination of a deposit agreement.
2 reports, 1 independent
Updated Sep 3
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Connect Biopharma Holdings Limited directly listed its ordinary shares on Nasdaq on September 3, 2025, following the termination of a deposit agreement.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- GlobeNewswireConnect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Hol
- GlobeNewswireConnect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma H